Heart-lung Machine Market Analysis

Heart-lung Machine Market Analysis

The single roller pump segment held over 60% of the heart-lung machine market share in 2022, due to several clinical benefits offered by single roller pump heart-lung machine. These machines offers several benefits in cardiac surgery and cardiopulmonary support. Single roller pump heart-lung machines propels the blood through the circuit, eliminating the need for complex mechanisms. These machines often incorporate safety features to ensure patient well-being during cardiopulmonary bypass
.

Safety mechanisms, such as bubble detectors, air removal systems, pressure alarms, and occlusion sensors, help monitor and control the flow of blood, ensuring the absence of air or obstructions that could potentially harm the patient. Single roller pump heart-lung machines minimize the risk of hemolysis by maintaining uniform blood flow without subjecting the blood cells to excessive mechanical stress or shear forces.
 

The cardiac surgeries segment dominated the heart-lung machine market with USD 139 million in 2022, attributed to increasing demand for heart-lung machines for the surgeries and diagnosis & treatment of several cardiac disorders. For instance, according to the WHO data, in 2021, around 17.9 million people globally were estimated to face mortality due to some form of cardiovascular disorder.
 

Heart-lung machines play a crucial role in cardiac surgeries and contribute to life-saving surgeries performed by healthcare professionals. These machines temporarily taking over the functions of the heart and lungs and provide vital cardiopulmonary support by maintaining oxygenation and circulation of the patient's blood. Heart-lung machines incorporate oxygenators that efficiently oxygenate the patient's blood, removing carbon dioxide and providing oxygen-rich blood to the body.
 

These machines minimize organ ischemia and reduces the risk of tissue damage and supports organ function by ensuring continuous blood flow and oxygenation during the procedure. Therefore, heart-lung machines provide critical support in cardiac surgeries, allowing surgeons to perform complex procedures with enhanced precision and patient safety, thereby contributing to the overall heart-lung machines market revenue.
 

The heart-lung machine market size from hospitals and clinics segment was reached USD 147 million in 2022. High adoption rate of advanced heart-lung machine offering enhanced therapeutic outcomes and convenient surgical procedures would surge the patient preference for hospital setting. Increasing admissions with chronic disorders and growing disease related awareness initiatives along with the availability of highly skilled healthcare practitioners are some additional aspects that are fueling the expansion of the hospitals and clinics segment positively.
 

Technological advancements in cardiac care, including surgical techniques and devices, have expanded the scope of interventions and surgeries performed in hospitals. Additionally, aging population is more susceptible to cardiovascular diseases and related complications, leading to increased hospital admissions. Thus, availability and accessibility to advanced heart-lung machines and better treatment & diagnosis coupled with the rising prevalence of chronic ailments will surge patient visits to hospitals and clinics.
 

North America heart-lung machine market is predicted to reach USD 141 million by 2032, on account of numerous variables including the presence of key companies, an increasing prevalence of cardiovascular diseases, and rising awareness regarding the benefits of heart-lung machines among others. Growing number of organ transplant surgeries have fostered the demand for heart-lung machines in the region. For instance, according to the U.S. Department of Health & Human Services, in 2021, around 41,000 organ transplant surgeries were performed in the U.S.
 

Heart-lung machines enable the safe and successful transplantation of vital organs, supporting patient outcomes and extending life-expectancy among patients. Development of sophisticated heart-lung machines with enhanced features, safety mechanisms, and monitoring capabilities have increased the product adoption rate in North America. As the incident cases of chronic ailment continues to rise in the region, the demand for efficient, proven, and effective heart-lung machines is projected to propel significantly. Thus, supporting initiatives aimed at improving healthcare outcomes, rising healthcare expenditure and increasing disease prone population would drive the regional revenue share positively.